Cover Image

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma

NK/T-cell lymphoma (NKTCL) is a rare type of non-Hodgkin lymphoma (NHL). Although L-asparaginase-based chemotherapy has significantly improved survival in early-stage patients, the prognosis is poor in advanced and relapsed or refractory patients. CD47 is a promising target for cancer immunotherapy....

Full description

Saved in:
Bibliographic Details
Main Authors: Liping Qin (Author), Yajun Li (Author), Ruolan Zeng (Author), Yizi He (Author), Xiaoyan Chen (Author), Ling Xiao (Author), Hui Zhou (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items